Mvasi

FDA commish cheers on biosimilars as Amgen, Allergan score OK for knockoff of Roche’s Avastin
Endpoints
Fri, 09/15/17 - 09:14 am
FDA
Scott Gottlieb
Amgen
Allergan
biosimilars
Mvasi
Roche
Avastin